Gilead Fixes the Price of COVID-19 Drug Remdesivir; the Government Secures the Bulk of Its Supply
Published
In the U.S., a health insurer insurer should be billed $3,120 per treatment course.
Full ArticlePublished
In the U.S., a health insurer insurer should be billed $3,120 per treatment course.
Full ArticleGilead Sciences said it will charge the U.S. government and other developed countries $390 per vial for its coronavirus-fighting..
The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical..